X-group (possible homology)

264 LigT-like

Ligands and drugs

746
Member domains
101
with ligand contacts (≤ 4 Å)
13.5% of members
89
with DrugDomain annotations
11.9% of members
66
with a DrugBank compound
8.8% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

11
Proteins with classified ligands
5
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Homogeneous metal compounds25.30.38×q = 0.10
Organic oxygen compounds52.22.31×not tested
Nucleosides, nucleotides, and analogues63.02.00×not tested
Homogeneous non-metal compounds42.31.71×not tested
Organoheterocyclic compounds11.70.60×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB03461NAPNicotinamide adenine dinucleotide phosphate7
DB03685U5PUridine monophosphate4
DB00171ATPATP3
DB02098A2PAdenosine-2'-5'-Diphosphate3
DB02580PG6Pentaglyme3
DB00131AMPAdenosine phosphate1
DB03512UVCUridine-2',3'-vanadate1
DB04205THPThymidine-3',5'-Diphosphate1
DB04315GDPGuanosine-5'-Diphosphate1

Most frequently bound compounds

PDB ligandNameDomains in contact
CLCHLORIDE ION29
2AMADENOSINE-2'-MONOPHOSPHATE10
NAPNADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE7
OVE2'-O-(sulfidophosphinato)adenosine4
U5PURIDINE-5'-MONOPHOSPHATE4
A2PADENOSINE-2'-5'-DIPHOSPHATE3
ATPADENOSINE-5'-TRIPHOSPHATE3
CAmetalCALCIUM ION3
PG61-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE3
3AM[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate2
MGmetalMAGNESIUM ION2
15PPOLYETHYLENE GLYCOL (N=34)1
ACK2',3'- cyclic AMP1
AMPADENOSINE MONOPHOSPHATE1
C5PCYTIDINE-5'-MONOPHOSPHATE1
GDPGUANOSINE-5'-DIPHOSPHATE1
HGmetalMERCURY (II) ION1
QQX[(3aR,4R,6R,6aR)-4-(6-aminopurin-9-yl)-2-oxidanyl-2-sulfanylidene-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-6-yl]methanol1
QQY[(3aR,4R,6R,6aR)-4-(6-aminopurin-9-yl)-2-oxidanylidene-2-sulfanyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-6-yl]methanol1
THPTHYMIDINE-3',5'-DIPHOSPHATE1